Orchard Therapeutics

United Kingdom · 200 Employees
At Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases. We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient's own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease in a single treatment. In 2018, the company acquired GSK's rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Today, Orchard is advancing a pipeline spanning pre-clinical, clinical and commercial stage HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist. Orchard has its global headquarters in London and U.S. headquarters in Boston. For more information, please visit www.orchard-tx.com,

概述

国家 United Kingdom
成立时间 2015
总部 108 cannon street, london, england, united kingdom
电话号码 +44203-808-8286
网站 http://www.orchard-tx.com
LinkedIn http://www.linkedin.com/company/orchard-therapeutics
Twitter https://twitter.com/orchard_tx
Facebook
员工数 200
行业 biotechnology,
简介 At Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases. We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient's own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease in a single treatment. In 2018, the company acquired GSK's rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Today, Orchard is advancing a pipeline spanning pre-clinical, clinical and commercial stage HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist. Orchard has its global headquarters in London and U.S. headquarters in Boston. For more information, please visit www.orchard-tx.com,

技术

Google Cloud Hosting

Hosting

Google Font API

Fonts

Google Tag Manager

Tag Management

Mobile Friendly

Other

New Relic

Web Performance Monitoring

Nginx

Load Balancers

Outlook

Email Providers

Route 53

Domain Name Services

Salesforce

Customer Relationship Management

Typekit

Fonts

Vimeo

Online Video Platforms

WordPress.org

CMS

常见问题

Orchard Therapeutics 在哪里?

Orchard Therapeutics 的总部位于 108 cannon street, london, england, united kingdom

Orchard Therapeutics 的电话号码是多少?

Orchard Therapeutics 的电话号码是 +44203-808-8286

Orchard Therapeutics 的官方网站是什么?

Orchard Therapeutics 的公司官方网站是 http://www.orchard-tx.com

Orchard Therapeutics 是做什么的?

Orchard Therapeutics 的业务有哪些?

stem cell technology,gene therapy,orphan diseases,paediatric diseases

Orchard Therapeutics 的年收入是多少?

Orchard Therapeutics 的收入是 14513000美元

Orchard Therapeutics 有多少员工?

Orchard Therapeutics 有 200 名员工

Orchard Therapeutics 属于哪个行业?

Orchard Therapeutics 从事以下行业: biotechnology

Orchard Therapeutics 使用什么技术?

Orchard Therapeutics 使用的一些流行技术包括: Google Cloud Hosting,Google Font API,Google Tag Manager,Mobile Friendly,New Relic,Nginx,Outlook,Route 53,Salesforce,Typekit,Vimeo,WordPress.org

如何联系 Orchard Therapeutics?

Orchard Therapeutics 联系信息: 电话号码:+44203-808-8286, 网站:http://www.orchard-tx.com, 邮箱:sel***@***.com

Orchard Therapeutics 的社交媒体链接是什么?

Orchard Therapeutics 领英:http://www.linkedin.com/company/orchard-therapeutics,fackbook:,twitte:https://twitter.com/orchard_tx

Orchard Therapeutics 是一家上市公司吗?

是的,Orchard Therapeutics是一家上市公司,在nasdaq公开挂牌上市,上市交易代码:ORTX

Orchard Therapeutics 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Orchard Therapeutics?

Orchard Therapeutics 有 0 家投资者,包括 。

管理层

Valentina Pennucci

Senior Associate, Gene and Cell Therapy

Simon Weatherley

Manager, Regulatory Operations and Systems

Maria Masdeu

Senior Associate, Gene and Cell Therapy Research

员工

Iryna Serdiuk

Global Supply Chain Inventory Associate

Chloe Moureau

Project Coordinator

Alan Jennings

Regulatory CMC Consultant

Jane Fitzpatrick

Senior Executive Assistant

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google